Samantha Pearce, EVP, Chief Commercial Officer at Jazz Pharmaceuticals plc (JAZZ), sold 6,907 shares at $235.41 ($1.6M) on 2026-05-28, disclosed to the SEC on 2026-06-01.
Open-market sale of $1.6M JAZZ by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| JAZZ | SELL | 2022-12-15 | $165K | — | Filing → |
| JAZZ | SELL | 2022-11-14 | $165K | — | Filing → |
| JAZZ | SELL | 2022-09-07 | $167K | — | Filing → |